ACTA VETERINARIA ET ZOOTECHNICA SINICA ›› 2019, Vol. 50 ›› Issue (2): 431-438.doi: 10.11843/j.issn.0366-6964.2019.02.022

Previous Articles     Next Articles

α-Mangostin Alleviates LPS-induced Inflammation by Inhibiting TLR4/NF-κB Signaling

ZOU Wenshu1, YIN Peng2, JIN Na1, GAO Qian1, LIU Fenghua1*   

  1. 1. Animal Science and Technology College, Beijing University of Agriculture, Beijing 102206, China;
    2. Institute of Microbiology, Chinese Academy of Sciences, Beijing 100101, China
  • Received:2018-07-04 Online:2019-02-23 Published:2019-02-23

Abstract:

The aim of this study was to prove that α-mangostin can alleviate the lipopolysaccharide (LPS)-induced inflammation of IEC-6 cells and reveal its mechanism. In this study, we constructed an LPS-induced inflammation model in IEC-6 cells in vitro, and examined whether LPS-induced inflammation was reduced by α-mangostin by means of the methods of rheumatology, ELISA, Q-PCR, and Western blot. The results showed that pretreatment with 5 μmol·L-1 α-mangostin significantly reduced the secretion of prostaglandin (PG) E2, interleukin (IL)-1β, IL-6, tumor necrosis factor (TNF)-α and the expression of COX-2, IL-6, TNF-α, IL-1β mRNA induced by LPS in IEC-6 cells (P<0.05). By investigating the inflammatory-related signaling pathway, NF-κB, we found that α-mangostin significantly inhibited the activation of TLR4 mRNA and NF-κB-related protein phosphorylated IκBα (pIκBα) and phosphorylated p65 (pp65) (P<0.05). In summary, α-mangostin can inhibit LPS-induced inflammation of IEC-6 cells through the TLR4/NF-κB signaling pathway and may be a potential treatment for inflammatory diseases.

CLC Number: